Cargando…
Microfluidic dose–response platform to track the dynamics of drug response in single mycobacterial cells
Preclinical analysis of drug efficacy is critical for drug development. However, conventional bulk-cell assays statically assess the mean population behavior, lacking resolution on drug-escaping cells. Inaccurate estimation of efficacy can lead to overestimation of compounds, whose efficacy will not...
Autores principales: | Mistretta, Maxime, Gangneux, Nicolas, Manina, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666435/ https://www.ncbi.nlm.nih.gov/pubmed/36379978 http://dx.doi.org/10.1038/s41598-022-24175-9 |
Ejemplares similares
-
RNase E and HupB dynamics foster mycobacterial cell homeostasis and fitness
por: Griego, Anna, et al.
Publicado: (2022) -
Delving Into the Functional Meaning of Phenotypic Variation in Mycobacterial Persistence: Who Benefits the Most From Programmed Death of Individual Cells?
por: Burgess Tornaletti, Laura, et al.
Publicado: (2020) -
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response
por: Petreus, Tudor, et al.
Publicado: (2021) -
A Microfluidic Platform for Cavitation-Enhanced Drug Delivery
por: Grisanti, Giulia, et al.
Publicado: (2021) -
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
por: Schuster, Brooke, et al.
Publicado: (2020)